Aktiesnakken — September 2013
-
Karo Bio achieves first milestone in Pfizer collaboration
STOCKHOLM, 5 September 2013 – The collaboration between Karo Bio AB and Pfizer Inc. has successfully resulted in a significant achievement within the...
GlobeNewswire News Room (www.globenewswire.com)
-
its a good day
-
Genmab er også urealistisk billig
-
nærmest ligeså gralt nu som i kurs 80 da de ekstra nyheder vi har efterfølgende er så meget værd
-
det er jeg nok ikke helt uenig i. Jeg synes slet ikke de har fået noget for den labelekspansion som potentielt er mange hundrede millioner om året nettp kontant
-
dara/revlimid kombi data er også mega vigtige. hvis dara både viser mega styrke i mono samt kombi skal der hæves nogle topsalgsestimater
-
Globo vender også fint idag
-
Der er kommet knald på Jinhui de senste dage, uden nyheder...
-
var der ikke lidt fremme om gode capesize rater?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind